Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 232

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Peptide/protein vaccine delivery system based on PLGA particles

Open access
Allahyari, Mojgan, Mohit, Elham · 2016 · Human Vaccines & Immunotherapeutics

Abstract

Due to the excellent safety profile of poly (D,L-lactide-co-glycolide) (PLGA) particles in human, and their biodegradability, many studies have focused on the application of PLGA particles as a controlled-release vaccine delivery system. Antigenic proteins/peptides can be encapsulated into or adsorbed to the surface of PLGA particles. The gradual release of loaded antigens from PLGA particles is necessary for the induction of efficient immunity. Various factors can influence protein release rates from PLGA particles, which can be defined intrinsic features of the polymer, particle characteristics as well as protein and environmental related factors. The use of PLGA particles encapsulating antigens of different diseases such as hepatitis B, tuberculosis, chlamydia, malaria, leishmania, toxoplasma and allergy antigens will be described herein. The co-delivery of antigens and immunostimulants (IS) with PLGA particles can prevent the systemic adverse effects of immunopotentiators and activate both dendritic cells (DCs) and natural killer (NKs) cells, consequently enhancing the therapeutic efficacy of antigen-loaded PLGA particles. We will review co-delivery of different TLR ligands with antigens in various models, highlighting the specific strengths and weaknesses of the system. Strategies to enhance the immunotherapeutic effect of DC-based vaccine using PLGA particles can be designed to target DCs by functionalized PLGA particle encapsulating siRNAs of suppressive gene, and disease specific antigens. Finally, specific examples of cellular targeting where decorating the surface of PLGA particles target orally administrated vaccine to M-cells will be highlighted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/21645515.2015.1102804

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 121

  1. 10.1586/erv.11.126 · DOI
  2. Amjadi I, 2013, Iran J Pharm Res, 12, 623
  3. 10.1016/j.nano.2010.02.002 · DOI · Paper page
  4. Mahboubian A, 2010, Iran J Pharm Res, 9, 369
  5. 10.1016/j.addr.2004.09.007 · DOI · Paper page
  6. 10.1016/j.addr.2011.05.021 · DOI · Paper page
  7. 10.1016/j.addr.2008.12.009 · DOI
  8. 10.1007/978-1-4939-0345-0_34 · DOI
  9. 10.1023/A:1026498209874 · DOI · Paper page
  10. 10.1517/17425247.2.1.29 · DOI · Paper page
  11. 10.1155/2011/181646 · DOI
  12. 10.3109/03639049809108571 · DOI · Paper page
  13. 10.1016/j.biomaterials.2007.08.015 · DOI · Paper page
  14. 10.1016/j.jconrel.2007.09.013 · DOI · Paper page
  15. 10.4161/hv.4.1.4886 · DOI
  16. 10.1351/PAC-REC-10-12-04 · DOI · Paper page
  17. 10.1016/j.colsurfb.2009.09.001 · DOI · Paper page
  18. 10.1016/j.addr.2012.10.003 · DOI · Paper page
  19. 10.1016/j.ejpb.2004.10.006 · DOI · Paper page
  20. 10.1016/S0168-3659(03)00194-9 · DOI · Paper page
  21. 10.1002/smll.200801855 · DOI · Paper page
  22. 10.1016/j.nano.2012.11.001 · DOI
  23. 10.1016/S0378-5173(02)00342-3 · DOI · Paper page
  24. 10.1007/s11095-009-0028-7 · DOI
  25. 10.1038/nature09737 · DOI · Paper page
  26. 10.1016/j.vetimm.2005.05.004 · doi:10.1016/j.vetimm.2005.05.004
  27. 10.1016/S0264-410X(01)00192-X · DOI
  28. 10.1016/j.vaccine.2011.11.057 · DOI
  29. 10.2174/156720109788680886 · DOI
  30. 10.1016/j.vaccine.2005.10.032 · DOI
  31. Huang SS, 2014, Int J Nanomedicine, 9, 813
  32. 10.4110/in.2011.11.3.163 · DOI
  33. 10.1016/j.jconrel.2006.01.012 · DOI
  34. 10.1186/1756-3305-6-34 · DOI
  35. 10.1016/j.exppara.2013.04.002 · DOI
  36. 10.1016/j.jconrel.2005.10.010 · DOI
  37. 10.1002/jps.20472 · doi:10.1002/jps.20472
  38. 10.1016/S0168-3659(00)00226-1 · DOI
  39. 10.1002/jps.10538 · DOI
  40. 10.1016/S0168-3659(98)00050-9 · DOI · Paper page
  41. 10.1023/A:1016278902839 · DOI
  42. 10.1016/j.addr.2012.09.004 · DOI · Paper page
  43. 10.1002/jbm.820240502 · DOI
  44. 10.1016/j.biomaterials.2012.03.041 · DOI · Paper page
  45. 10.1016/j.ijpharm.2011.05.049 · DOI · Paper page
  46. 10.1016/j.ijpharm.2008.04.042 · DOI · Paper page
  47. 10.1016/S0927-7765(00)00148-X · DOI
  48. 10.1208/pt0804098 · DOI
  49. 10.1016/j.ijpharm.2007.11.012 · DOI · Paper page
  50. 10.1016/S0142-9612(99)00002-2 · DOI · Paper page
  51. 10.1590/S0100-879X1999000200005 · DOI
  52. 10.1016/j.ijpharm.2011.01.045 · DOI
  53. 10.1016/0142-9612(95)93575-X · DOI · Paper page
  54. 10.1016/j.polymer.2006.01.021 · DOI
  55. 10.1016/j.ejpb.2012.11.006 · DOI
  56. 10.1016/S0169-409X(02)00228-4 · DOI · Paper page
  57. 10.1021/bm050228k · DOI · Paper page
  58. 10.1081/DDC-100100328 · DOI
  59. 10.1016/S0168-3659(01)00446-1 · DOI
  60. 10.1002/jbm.10019 · DOI · Paper page
  61. 10.1016/j.addr.2014.05.011 · DOI
  62. 10.1016/j.jconrel.2010.08.012 · DOI · Paper page
  63. 10.1016/j.ymeth.2006.05.017 · DOI · Paper page
  64. 10.1016/S0264-410X(00)00433-3 · DOI
  65. 10.1016/S0264-410X(02)00435-8 · DOI · Paper page
  66. 10.1016/j.vaccine.2003.10.020 · DOI
  67. 10.1007/s11095-010-0094-x · DOI
  68. 10.1016/0264-410X(93)90387-D · DOI · Paper page
  69. Eldridge JH, 1991, Infect Immun, 59, 2978, 10.1128/IAI.59.9.2978-2986.1991 · DOI · Paper page
  70. 10.1002/eji.200737984 · DOI · Paper page
  71. 10.1211/0022357044418 · DOI
  72. 10.1016/S0264-410X(01)00508-4 · DOI
  73. 10.1208/s12248-014-9624-5 · DOI
  74. Xiao X, 2013, Int J Nanomedicine, 8, 4553
  75. 10.1021/mp100255c · DOI · Paper page
  76. Tafaghodi M, 2010, Tropical biomedicine, 27, 639
  77. Santos DM, 2012, Int J Nanomedicine, 7, 2115
  78. 10.1016/j.nano.2013.04.003 · DOI
  79. 10.1080/10611860801900462 · DOI
  80. 10.1208/s12248-009-9089-0 · DOI
  81. 10.1088/0957-4484/23/32/325101 · DOI
  82. Fairley SJ, 2013, Int J Nanomedicine, 8, 2085
  83. 10.1182/blood-2011-07-367615 · DOI · Paper page
  84. 10.1016/j.ijpharm.2008.08.039 · DOI
  85. 10.1016/j.addr.2013.05.013 · DOI · Paper page
  86. 10.3109/02652048.2014.885608 · doi:10.3109/02652048.2014.885608
  87. 10.1016/j.jconrel.2004.09.014 · DOI · Paper page
  88. 10.1128/IAI.73.2.828-833.2005 · DOI
  89. 10.1007/s11095-007-9318-0 · DOI · Paper page
  90. 10.1007/s00436-010-2176-4 · DOI
  91. 10.4110/in.2013.13.1.30 · DOI
  92. 10.1016/j.vaccine.2003.12.032 · DOI · Paper page
  93. 10.1016/j.biomaterials.2014.05.067 · DOI
  94. 10.1002/jps.21065 · DOI
  95. 10.1016/j.ejpb.2008.03.015 · DOI
  96. 10.1080/10611860903119656 · doi:10.1080/10611860903119656
  97. 10.1016/j.vaccine.2014.05.071 · DOI
  98. 10.1016/j.jconrel.2011.07.029 · DOI
  99. 10.1371/journal.pone.0031472 · doi:10.1371/journal.pone.0031472
  100. 10.1016/j.vaccine.2006.01.011 · DOI · Paper page
  101. 10.1080/02652040701443700 · DOI
  102. 10.1208/s12248-009-9169-1 · DOI
  103. 10.1016/j.vaccine.2010.06.121 · DOI · Paper page
  104. 10.1021/mp400092y · doi:10.1021/mp400092y
  105. 10.1016/j.jconrel.2008.06.003 · DOI
  106. 10.1002/jbm.a.32860 · DOI
  107. 10.1016/j.biomaterials.2011.02.011 · DOI
  108. 10.1016/j.nano.2013.08.012 · DOI
  109. 10.1080/10611860701637982 · DOI · Paper page
  110. 10.1016/j.ejpb.2009.04.009 · DOI · Paper page
  111. 10.3109/10611861003733946 · DOI · Paper page
  112. 10.1016/j.ijpharm.2014.06.052 · DOI
  113. 10.1016/j.biomaterials.2013.11.073 · DOI
  114. Saluja SS, 2014, Int J Nanomedicine, 9, 5231
  115. 10.1016/S0169-409X(98)00012-X · DOI · Paper page
  116. 10.1016/j.jconrel.2012.01.043 · DOI · Paper page
  117. 10.1016/j.jconrel.2014.07.040 · DOI · Paper page
  118. 10.1016/j.biomaterials.2006.10.034 · DOI
  119. 10.1016/j.actbio.2013.12.050 · DOI
  120. 10.1016/j.biomaterials.2013.10.009 · doi:10.1016/j.biomaterials.2013.10.009
  121. 10.1016/j.jconrel.2014.06.027 · DOI · Paper page

Cited by

See all 232

Metadata

Authors
Allahyari, M., & Mohit, E.
Venue
Human Vaccines & Immunotherapeutics
Published
2015-10-29
Volume
12
Issue
3
Pages
806-828
ISSN
  • 2164-5515 (ISSN-L)
  • 2164-554X
OpenAlex
W2203910881
Cited by
232
References
13
FWCI
3.44
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Peptide/protein vaccine delivery system based on PLGA particles. https://app.cochat.ai/papers/10.1080/21645515.2015.1102804
The paper
Allahyari, M., & Mohit, E. (2016). Peptide/protein vaccine delivery system based on PLGA particles. Human Vaccines & Immunotherapeutics. https://doi.org/10.1080/21645515.2015.1102804

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.